EGFR and non-small cell lung carcinoma: At the end of all three rounds of concept elicitation interviews, 12 symptomatic AEs comprising 25 items that were relevant for patients with NSCLC with EGFR Exon 20ins were selected from the PRO‐CTCAE (Table 2).